Document is current

Article History

Received: 4 July 2024

Accepted: 2 January 2025

First Online: 1 February 2025

Declarations

:

: Ethics approval does not apply to this study because there are no patients involved.

: Not applicable, no personal data have been included in the publication.

: ROLL has received fees for academic services and grants to attend international meetings from Abbot, CSL, GSK, Moderna, MSD, Novavax, Pfizer, Roche and Sanofi. JDD reports personal fees/grants from GSK, Sanofi Pasteur and MSD and nonfinancial support from Sanofi Pasteur and MSD. AGM has received grants paid to his institutions by Sanofi, GSK, and Pfizer. He has also received personal consulting fees from Sanofi, MSD, and Moderna, as well as for lectures and congress presentations from GKS, HIPRA, Astra-Zeneca, Novavax, Pfizer and Jannsen. He has received support for attending meetigs/travel by Pfizer, MSD, GSK, and Sanofi. Finally, he declares having participated in safety monitory boards for Pfizer, Hipra and Novavax. ERM has participated in advisory boards, conferences, courses and lectures organized by Glaxo SmithKline, Sanofi Pasteur, MSD, GSK, Seqirus, Pfizer, Moderna, Takeda, and AstraZeneca. She has also participated in data safety or advisory boards from Pfizer, Sanofi, MSD, Moderna, Takeda and GSK. FMT has received honoraria and/or reimbursement for participation fees/travel expenses from GSK, Pfizer Inc, Sanofi Pasteur, MSD, Seqirus, Biofabri, and Janssen for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. He has also acted as principal investigator in randomized controlled trials sponsored by the above-mentioned companies as well as by Ablynx, Gilead, Regeneron, Roche, Abbott, Novavax, and MedImmune, with honoraria paid to his institution. JMAP declares having received consulting fees from Sanofi. JLLBC, PIPJ and JMFA are employees of Sanofi and may hold shares and/or stock options in the company.